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1586 The Journal of Thoracic and CardObjective: Reactive free radical species are thought to be involved in ischemic
spinal cord injury. We investigated the effects of edaravone (Mitsubishi Pharma Co,
Tokyo, Japan), a free radical scavenger, on spinal ischemia-reperfusion injury in a
rabbit model. We also sought to estimate free radicals in the spinal cord using the
microdialysis method.
Methods: Spinal cord ischemia was induced in New Zealand White rabbits. The
animals were then divided into 4 groups. In the first experiment, which was carried
out in group A (non–edaravone treated) and group B (edaravone treated), we
assessed neurologic function and evaluated spinal cord histopathology. In the
second experiment, which was performed in group C (non–edaravone treated) and
group D (edaravone treated), we sequentially estimated the level of free radical
species in the spinal cord with the microdialysis method.
Results: In the first experiment group B showed better neurologic function than
group A. The number of viable neurons in the spinal cord gray matter was also
higher in group B than in group A. The second experiment revealed that the level
of free radical species was lower in group D at 75, 90, and 150 minutes after the
beginning of reperfusion compared with levels seen in group C. The appearance of
free radical species in the latter group was found to have a biphasic pattern, with
peaks at 75 and 150 minutes after the beginning of reperfusion.
Conclusion: Edaravone exerted a significant protective effect on the spinal cord
against ischemia-reperfusion injury by suppressing the level of free radical species,
which was demonstrated with the microdialysis method.
Paraplegia or paraparesis resulting from spinal cord ischemia during de-scending or thoracoabdominal aortic aneurysm surgery is a dreaded result.Various methods have been used for the prevention of ischemic spinal
cord injury, such as systemic or topical cooling, distal aortic perfusion, inter-
costal artery reimplantation, cerebrospinal fluid drainage, and pharmacologic
agents.1-3 Intraoperative monitoring of spinal cord function, such as motor
evoked potential and sensory evoked potential, has also been in clinical use for
many years.4,5 Although neurologic deficits have significantly decreased in
recent times because of the use of these adjuncts, the incidence of paraplegia is
still high at 6.6% to 8.3% in the patients with extent II thoracoabdominal aortic
aneurysms.1-3,6 With a view to further improving spinal cord protection, a
number of pharmacologic agents with varying mechanisms of action have been
brought under experimental evaluation and clinical trial. Earlier, we reported our
experimental study on spinal cord protection with N-methyl-D-aspartate recep-
tor antagonist (dextrorphan) and Na-Ca2 channel blocker (NS-7).7,8 Unfortu-
nately, these chemicals are not in clinical use because of their unacceptable
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Pside-effect profile. With an aim to find a clinically appli-
cable pharmacologic agent, we directed our attention
toward the free radical hypothesis of central nervous
system (CNS) ischemic injury and a way to prevent it.9 In
this connection we considered the potential of edaravone
(Mitsubishi Pharma Co, Tokyo, Japan), a commercially
available free radical scavenger, the cerebral protective
effects of which have been demonstrated both experimen-
tally and clinically.10,11 We thought that the spinal cord,
a part of the CNS, could also be protected from ischemic
injury by edaravone. In the present study we assessed
motor function status, as well as spinal cord histopathol-
ogy, to evaluate the effect of prophylactically adminis-
tered edaravone on the rabbit spinal cord after ischemia-
reperfusion injury. Additionally, we sequentially
estimated the level of free radicals within the spinal cord
by using the microdialysis method to document the effect
of edaravone.
Materials and Methods
Animal Care and Surgical Procedure
We used male New Zealand white rabbits weighing 2.5 to 3.5 kg.
All animals received humane care in compliance with the “Guide
for the care and use of laboratory animals” prepared by the
Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press, revised
1996, and the “Guidelines for animal experimentation” of Hamamatsu
University School of Medicine.
Creating a Spinal Cord Ischemia Model
The animals were anesthetized with intravenous sodium pento-
barbital (25 mg/kg). A continuous intravenous infusion line was
secured at the marginal ear vein with a 24-gauge catheter. An
arterial line was secured in the left common carotid artery with
a 24-gauge catheter to monitor the proximal arterial pressure.
Rectal temperature was continuously monitored with a flexible
probe. An electric blanket (Sharp Co, Osaka, Japan) was used
for retaining warmth, so that any decrease in temperature would
not exceed 1°C. A 4F balloon-tipped catheter (Goodtec Inc,
Huntington Beach, Calif) was inserted through an arteriotomy
in the left femoral artery into the abdominal aorta for a distance
of about 15 cm.12 Preliminary investigations, including lapa-
rotomy, confirmed that the balloon came to lie 0.5 to 1.2 cm
distal to the left renal artery. After intravenous administration
of heparin (100 U/kg), the balloon was inflated to obstruct the
aortic blood flow. Complete cessation of blood flow was con-
firmed by a pressure decrease in the abdominal aorta measured
Abbreviations and Acronyms
CNS central nervous system
HPF  2-[6-(4=-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]
benzoic acidwith the help of a pressure sensor attached at the distal end of
The Journal of Thoracicthe balloon. In this study we applied a 30-minute obstruction of
the abdominal aorta. A total of 30 animals underwent spinal
cord ischemia-reperfusion injury. The animals were then ran-
domly divided into 4 groups. The first experiment was carried
out in groups A (n  10) and B (n  10), with only the latter
receiving intravenous edaravone. The rabbits of both groups
were assessed for hind-limb motor function 24 and 48 hours
after the beginning of reperfusion. They were then killed, and
their lumbar spinal cords were removed for histopathologic
examination. In the second experiment (groups C and D) we
applied the microdialysis method to estimate the level of free
radical species within the spinal cord. Animals in group D (n 
5) received edaravone, whereas those in group C (n  5) did
not.
Drug Delivery
In groups B and D intravenous edaravone was continuously
delivered at a rate of 2.5 mg/kg/h with an infusion pump
(Terumo, Tokyo, Japan). The dosage was decided on the basis
of previous studies that report the effective dose of edaravone to
be 1.5 to 3.0 mg/kg in cerebral ischemic rat models.13,14 We
started administration of the drug 30 minutes before the ob-
struction of blood flow because according to a previous report,
a steady plasma level of edaravone was obtained 30 minutes
after the beginning of intravenous injection.15 Because it is not
clear when the influence of free radicals on spinal tissue dis-
appears, we performed continuous administration of edaravone
until 180 minutes after the beginning of reperfusion. In the
non-edaravone–treated groups (groups A and C) normal saline
solution was delivered intravenously under similar conditions
as in the edaravone-treated groups.
Microdialysis Method
In the second experiment animals underwent tracheostomy in
the supine position and were then turned to the prone position.
Vecuronium bromide (0.1 mg/kg) was administered as a muscle
relaxant to avoid movement while doing laminectomy, and
mechanical ventilation was started. The vertebral canal was
opened at the level of L3. The dura mater was removed, and the
spinal cord was exposed. A microdialysis probe with a mem-
brane length of 2 mm (CMA Microdialysis Inc, North Chelms-
ford, Mass) was inserted into the spinal cord and stabilized. The
probe was connected to a microinjection pump with fine mi-
crodialysis catheters (CMA Microdialysis Inc). In this study
2-[6-(4=-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid
(HPF; Daiichi Pure Chemicals Co, Tokyo, Japan) solution was
used as perfusate. HPF becomes strongly fluorescent when it
reacts with hydroxyl radical or peroxynitrite (Figure 1).16 Free
radicals produced in the spinal tissue react with the HPF
through the microdialysis membrane. HPF solution, which was
diluted to a concentration of 50 mol/L, was perfused at a rate
of 2 L/min until 180 minutes after the beginning of reperfu-
sion. HPF was collected every 15 minutes after it had passed
through the microdialysis circuit. It was then measured for its
fluorescence intensity with a spectrofluorometer (Japan Spec-
troscopic Co, Tokyo, Japan) at 515 nm, with excitation at 490
nm. Higher intensity of fluorescence meant a higher level of
free radicals.
and Cardiovascular Surgery ● Volume 130, Number 6 1587
Cardiopulmonary Support and Physiology Suzuki et al
CSPNeurologic Evaluation
Neurologic status was scored on the basis of assessment of hind-
limb motor function 24 and 48 hours after reperfusion in the first
experiment according to the Johnson neurologic recovery scale17:
0, hind-limb paralysis; 1, severe paraparesis; 2, functional move-
ment but no hopping; 3, ataxic hopping; 4, minimal ataxia; 5,
normal.
Histopathologic Examination
After neurologic evaluation, the animals in the first experiment
were killed with an overdose of intravenous sodium pentobarbital.
The lumbar spinal cord was quickly removed and fixed overnight
in 10% buffered formalin. Paraffin-embedded sections were pro-
cessed for hematoxylin and eosin staining, and histopathologic
evaluation of spinal cord tissue from the L3 segment was per-
formed under a light microscope. The examination included a
count of the viable neurons per section in the gray matter.
Statistical Analysis
Statistical analysis of the neurologic recovery score was performed
with the nonparametric Mann-Whitney U test. Statistical analyses
of the mean proximal arterial pressure, rectal temperature data, and
numbers of the remaining neurons were done with the unpaired
t test. In the analyses of fluorescence intensity, the unpaired t test
Figure 1. The putative reaction scheme of 2-[6-(4=-hydr
which is almost completely nonfluorescent, is o-dear
yield strongly fluorescent fluorescein.
TABLE 1. Mean proximal arterial pressure and lowest rec
Before ischemia
(mm Hg)
During ischemia
(mm Hg) 60 min (m
Group A 107 10 118 14 103
Group B 116 6 121 6 110
Group C 118 2 120 7 110
Group D 118 9 121 5 107
Values represent means standard deviation. Groups A (n 10) and C (n
continuous intravenous infusion of edaravone at the rate of 2.5 mg/kg/h.
1588 The Journal of Thoracic and Cardiovascular Surgery ● Decwas used for comparison between groups C and D, whereas the
paired t test was used for comparison within group C.
Results
Blood Pressure and Rectal Temperature
Mean proximal arterial pressures and the lowest rectal tem-
peratures are shown in Table 1. In both experiments there
were no differences in mean proximal aortic pressures and
rectal temperatures between the edaravone-treated and non-
edaravone–treated groups.
Neurologic Evaluation
Neurologic status is shown in Figure 2. In group A the
Johnson neurologic recovery score was 0 (hind-limb paral-
ysis) in all animals at 24 and 48 hours after the beginning of
reperfusion. In group B the scores at 24 hours after the
beginning of reperfusion were as follows: 5 in 3 animals, 4
in 1 animal, 3 in 1 animal, and 0 in 2 animals, with an
average score of 3.4  1.8. At 48 hours after the beginning
of reperfusion, the scores were as follows: 5 in 5 animals, 4
in 1 animal, 3 in 1 animal, and 0 in 2 animals, with an
average of 3.3  2.2. In comparison with group A, animals
henoxy-3H-xanthen-3-on-9-yl]benzoic acid (HPF). HPF,
d on reaction with reactive oxygen species (ROS) to
emperature during obstruction of the abdominal aorta
After beginning of reperfusion: Lowest rectal
temperature (°C)) 120 min (mm Hg) 180 min (mm Hg)
110 12 112 10 37.9  0.5
122 11 116 7 38.1  0.9
115 11 111 10 38.1  0.2
117 9 118 6 38.3  0.4
nderwent spinal ischemia alone. Groups B (n 10) and D (n 5) receivedoxy)p
ylatetal t
m Hg
15
10
13
11
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Pin group B had significantly higher scores (P  .0025 at 24
hours and P  .0025 at 48 hours). The neurologic scores in
group B at 24 and 48 hours after the beginning of reperfu-
sion were similar.
Histopathologic Evaluation
Histopathologic findings are shown in Figure 3. The lumbar
spinal cords of rabbits with fully preserved neurologic func-
tion (score 5) after edaravone administration were histolog-
ically well preserved. The cross-sections of the spinal cord
showed normal-looking motor neurons having clear nucle-
oli and Nissl substance (Figure 3, group B). On the other
hand, spinal cord sections of rabbits with paralysis (score 0)
demonstrated necrotic changes in the form of destruction
and vacuolization of the gray matter, pyknosis of neurons,
and eosinophilic changes of the cytoplasm (Figure 3, group A).
The numbers of viable neurons in the gray matter were 20.0
10.8 in group A and 81.5  27.2 in group B (P  .008,
Figure 4). Histopathologic findings correlated well with
neurologic functions in both the edaravone-treated and non-
edaravone–treated groups.
Microdialysis Method
The fluorescence intensities of HPF are shown in Figure 5.
The intensity in groups C and D at 75 minutes, 90 minutes,
and 150 minutes after the beginning of reperfusion were
1341  69 and 1225  27, 1294  51 and 1187  60, and
Figure 2. Neurologic status 24 and 48 hours after the b
recovery scale. Average scores represent means  sta
comparison with group A at 24 and 48 hours after the b
with group A; at 48 hours: **P  .0025 compared with1245  19 and 1168  25, respectively. The fluorescence
The Journal of Thoracicintensities of HPF were significantly lower in group D at 75,
90, and 150 minutes after the beginning of reperfusion
compared with those in group C (P  .0162, P  .00158,
and P  .0012, respectively). This means that the level of
free radicals was lower in the edaravone-treated animals.
Comparing the fluorescence intensity at 75 minutes after the
beginning of reperfusion with those at 15, 30, and 45
minutes after the beginning of reperfusion in group C, the
intensities at 75 minutes were significantly higher (P 
.0274, P .0044, and P .0019, respectively). This means
that the production of free radicals in the ischemic spinal
cord began to increase between 60 and 75 minutes after the
beginning of reperfusion. Although not statistically signifi-
cant, the fluorescence intensity of HPF tended to show
another peak between 150 and 165 minutes after the begin-
ning of reperfusion in group C.
Discussion
In this study we demonstrated that edaravone was effective
in preventing motor function and histopathologic complica-
tions of spinal cord ischemia-reperfusion injury in rabbits.
Earlier, Takahashi and colleagues18 applied edaravone in
rabbit spinal ischemia models and documented its effective-
ness by immunohistochemically assessing the levels of su-
peroxide dismutase and nitric oxide synthatase, but the
study did not demonstrate a direct relationship between the
ing of reperfusion, as evaluated by using the Johnson
d deviation. Group B had significantly higher scores in
ning of reperfusion (at 24 hours: *P  .0025 compared
up A).eginn
ndar
egin
groadministration of edaravone and the decrease in the level of
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free radicals. It is for the first time that we used the micro-
dialysis method to document the production of free radicals
within the spinal cord as a result of ischemia-reperfusion
injury, which were scavenged by edaravone. It is interesting
that the inhibition of free radical production by edaravone is
directly demonstrable. Free radical species lead to oxidation
of lipids, proteins, and nucleic acids, which might alter cel-
lular function in a critical way, resulting in CNS injury and
subsequent neurologic dysfunction.19,20 Normally, toxic free
radical species are converted to harmless metabolites by su-
peroxide dismutase or catalase.9,20 The oxidative damage po-
tential and the antioxidant defense capacity of the body are in
a dynamic equilibrium at all times.21 Once this equilibrium is
disturbed, as in ischemic injury, there is excessive production
Figure 3. Histopathologic findings of the spinal cord s
the beginning of reperfusion. Sections from each grou
magnification: left panel, 40; right panel, 400.) The
spinal cords showed necrotic changes, including dest
gray matter was largely preserved, with normal-lookinof free radical species, which ultimately leads to an increase in
1590 The Journal of Thoracic and Cardiovascular Surgery ● Decthe level of hydroxyl radical.21,22 Hydroxyl radical is one of the
most reactive free radical species and is known to hydroxylate
almost all components of the living cell, resulting in injury and
cell death.23 In previous reports excessive levels of hydroxyl
radical were documented in the damaged brain.24,25 As with
ischemic brain injury, hydroxyl radical was also shown to
increase in the regions of ischemia-reperfusion injury of the
spinal cord.9,26 Because free radical species have a very
short half-life, it is necessary to apply trapping agents, such
as salicylic acid or phenylalanine, to detect them. However,
the chemical compounds resulting from trapping of free
radical species are very unstable substances. Moreover, it is
difficult to accurately measure a very small quantity of these
compounds.27 We thought that it was possible to estimate
ns stained with hematoxylin and eosin 48 hours after
re examined with 2 different magnifications. (Original
l cord of sham control animals was intact. In group A
n and vacuolization of the gray matter. In group B the
otor neurons.ectio
p we
spina
ructio
g meven a small quantity of free radical species using the
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Pmicrodialysis method. The advantage of this method is that
it allows for sequential evaluation of any fluctuation in the
level of free radical species throughout the duration of
ischemia and reperfusion of the spinal cord in a dynamic
manner. In the second experiment we found that the fluo-
rescence intensity peaked at 75 minutes after the beginning
of reperfusion in the non-edaravone–treated group. This
suggests that the production of free radical species was the
highest between 60 and 75 minutes after the beginning of
reperfusion. It also indicates that tissue injury in the spinal
cord might be more severe a certain time after the com-
mencement of reperfusion rather than immediately after it.
Figure 4. The number of viable neurons in the gray matter of lumbar
spinal cord sections stained with hematoxylin and eosin. Group B
had significantly more viable neurons than group A (*P  .008
compared with group A).
Figure 5. The fluorescence intensities of 2-[6-(4=-hydro
minutes from 15 to 180 minutes after the beginning of r
at 75, 90, and 150 minutes after the beginning of repe
minutes: **P  .00158; at 150 minutes: #P  .0012).
The Journal of ThoracicIt is thought that the production of free radicals gradually
increases as blood flow to the ischemic regions recovers and
reaches a delayed peak.28 According to the findings of brain
ischemia-reperfusion injury, the peak of free radical appear-
ance varies between 15 and 40 minutes after reperfu-
sion.25,28 In our experiment the peak appeared to be more
delayed. We think that the following factors might have
caused this delay. The extent and severity of tissue injury
experienced because of ischemia vary with experiments
because of difference in ischemic time. Moreover, time
required for the recovery of blood flow to ischemic regions
differs between the brain and spinal cord because of the
difference in the pattern of the collateral blood flow in the 2
regions. Although the production of free radicals was bi-
phasic in our study, it is possible that the latter peak was
caused by inflammatory cells, particularly neutrophils,
which are a well-known source of several kinds of free
radicals.29 The level of free radicals in the edaravone-
treated group was particularly lower in comparison with the
non-edaravone–treated group at 75, 90, and 150 minutes
after the beginning of reperfusion. It suggests that the ap-
pearance of free radical species was suppressed by admin-
istering edaravone. We think that the free radicals that were
produced as a result of ischemia-reperfusion injury were
scavenged by edaravone.
However, the findings of this experimental study should
be interpreted bearing in mind its limitations. The spinal
cord circulation in rabbits might not be quite the same as it
is in human subjects. Drug toxicity of edaravone is another
concern that is likely to limit its clinical application. Acute
renal failure and increased liver transaminases have been
henoxy-3H-xanthen-3-on-9-yl]benzoic acid at every 15
fusion. Intensities were significantly lower in group D
on than in group C (at 75 minutes: *P  .0162; at 90xy)p
eper
rfusiand Cardiovascular Surgery ● Volume 130, Number 6 1591
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Moreover, it should be emphasized that edaravone does
not have any effect on the tissue injury experienced at the
onset of ischemia. It only acts on the subsequent free
radical injury caused at the time of reperfusion. Therefore
complete neurologic recovery after spinal cord ischemia-
reperfusion injury should not be expected with the use of
edaravone.
In conclusion, prophylactic administration of edaravone,
a free radical scavenger, in a rabbit spinal ischemia model
resulted in partial prevention of neurologic functional im-
pairment, with an increase in the number of viable motor
neurons in the gray matter. The microdialysis method with
HPF was useful in evaluating the level of free radical
species. With this method, it was possible to demonstrate
that free radicals produced within the spinal cord as a result
of ischemia-reperfusion injury were scavenged by edara-
vone. Prophylactic administration of edaravone might be a
useful adjunct for spinal cord protection during descending
or thoracoabdominal aortic operations.
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